HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
About this episode
This episode features a rapid case review of HER2-altered non-small cell lung cancer with insights from Dr Mark Jeng and Dr Joshua K Sabari.
Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics: Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00) Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07) Case: A man in his mid 80s experiences metastatic recurrence after resection of PD-L1-positive, HER2-mutant metastatic NSCLC (17:50) CME information and select publications
People in this episode
Host: Dr. Neil Love
Guests: Dr Mark Jeng, Dr Joshua K Sabari
Topics covered
- HER2-Altered Non-Small Cell Lung Cancer
- zongertinib
- metastatic NSCLC
- case review
- oncology
Keywords
- HER2
- non-small cell lung cancer
- zongertinib
- metastatic cancer
- oncology case review
Mentioned in this episode
Products: zongertinib
More episodes of Oncology Today with Dr Neil Love
- Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
- HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy
- For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress
- Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
- Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
- Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.